Patents by Inventor Shiuh-Bin Fang

Shiuh-Bin Fang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11504406
    Abstract: A probiotic combination for inhibition of vancomycin-resistant enterococci includes Bacillus coagulans, Lactobacillus rhamnosus CG, Lactobacillus reuteri, and Lactobacillus acidophilus. The probiotic combination can inhibit growth, host cell attachment, or virulence of vancomycin-resistant enterococci, and also can inhibit virulence gene expression of vancomycin-resistant enterococci. The virulence gene includes at least one of asa1, acm, ebpA, ebpB, ebpC, efaA, sagA, esp, sgrA, and scm genes.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: November 22, 2022
    Assignees: DELTA ELECTRONICS, INC., TAIPEI MEDICAL UNIVERSITY
    Inventors: Shiuh-Bin Fang, Kun-Nan Tsai, Wei-Sheng Sun, Yu-Hsuan Ho, Yuarn-Jang Lee
  • Publication number: 20210285028
    Abstract: Disclosed is a method and a device for determining whether a sample contains ampicillin-resistant (AMP-R) non-typhoid Salmonella (NTS). The method comprises detecting, in the sample, the presence of a combination of certain genes or their gene products, wherein the presence of said combination indicates the sample contains AMP-R NTS.
    Type: Application
    Filed: May 21, 2019
    Publication date: September 16, 2021
    Applicant: TAIPEI MEDICAL UNIVERSITY
    Inventors: Shiuh-Bin FANG, Wei-Chiao CHANG, Wan-Hsuan CHOU, Ke-Chuan WANG
  • Publication number: 20210060092
    Abstract: A probiotic combination for inhibition of vancomycin-resistant enterococci includes Bacillus coagulans, Lactobacillus rhamnosus CG, Lactobacillus reuteri, and Lactobacillus acidophilus. The probiotic combination can inhibit growth, host cell attachment, or virulence of vancomycin-resistant enterococci, and also can inhibit virulence gene expression of vancomycin-resistant enterococci. The virulence gene includes at least one of asa1, acm, ebpA, ebpB, ebpC, efaA, sagA, esp, sgrA, and scm genes.
    Type: Application
    Filed: March 13, 2020
    Publication date: March 4, 2021
    Inventors: Shiuh-Bin Fang, Kun-Nan Tsai, Wei-Sheng Sun, Yu-Hsuan Ho, Yuarn-Jang Lee
  • Publication number: 20080050769
    Abstract: This invention disclosed a method to detect bioparticles in the biological samples (stools, urine, or other body fluids). Bioparticles (e.g. virus, bacteria, and cells) often serve as carrier/indicator of pathogens and/or toxins. The method employs a substrate with interlaced comb-like electrodes on which a certain amount of sample mixed with antibodies-coated gold nanoparticles is dropped. Then the alternative signals with specific frequency bands are applied on the comb-like electrodes so that under such a DEP force the Au-modified bioparticles can be separated from the other constituents of the sample and can be absorbed effectively onto the edges of the electrodes. After rinsed with water to remove the residual sample several times, the device will be measured for the impedance of the absorbed bioparticles on the edges of the electrodes. The measured impedance deviation in comparison with that of the reference empty comb-like electrodes will quantify the amount of the absorbed bioparticles.
    Type: Application
    Filed: August 27, 2007
    Publication date: February 28, 2008
    Inventors: Jung-Tang Huang, Yu-Huan Lin, Shao-Yi Hou, Shiuh-Bin Fang